GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) » Definitions » Dividend Payout Ratio

GlaxoSmithKline Pharmaceuticals (BOM:500660) Dividend Payout Ratio : 0.00 (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals Dividend Payout Ratio?

GlaxoSmithKline Pharmaceuticals's dividend payout ratio for the months ended in Mar. 2024 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of GlaxoSmithKline Pharmaceuticals Ltd is 0.78, which seems too high.

The historical rank and industry rank for GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:

BOM:500660' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.64   Med: 0.78   Max: 1.41
Current: 0.78


During the past 13 years, the highest Dividend Payout Ratio of GlaxoSmithKline Pharmaceuticals was 1.41. The lowest was 0.64. And the median was 0.78.

BOM:500660's Dividend Payout Ratio is ranked worse than
87.97% of 424 companies
in the Drug Manufacturers industry
Industry Median: 0.34 vs BOM:500660: 0.78

As of today (2024-06-08), the Dividend Yield % of GlaxoSmithKline Pharmaceuticals is 1.29%.

During the past 13 years, the highest Trailing Annual Dividend Yield of GlaxoSmithKline Pharmaceuticals was 4.27%. The lowest was 0.86%. And the median was 1.70%.

GlaxoSmithKline Pharmaceuticals's Dividends per Share for the months ended in Mar. 2024 was ₹0.00.

During the past 12 months, GlaxoSmithKline Pharmaceuticals's average Dividends Per Share Growth Rate was 6.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 17.00% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 14.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of GlaxoSmithKline Pharmaceuticals was 45.80% per year. The lowest was -17.60% per year. And the median was 12.10% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


GlaxoSmithKline Pharmaceuticals Dividend Payout Ratio Historical Data

The historical data trend for GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pharmaceuticals Dividend Payout Ratio Chart

GlaxoSmithKline Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.75 0.64 1.38 0.84 0.78

GlaxoSmithKline Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.53 - - -

Competitive Comparison of GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio falls into.



GlaxoSmithKline Pharmaceuticals Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2024 )/ EPS without NRI (A: Mar. 2024 )
=32/ 40.83
=0.78

GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 11.06
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GlaxoSmithKline Pharmaceuticals (BOM:500660) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


GlaxoSmithKline Pharmaceuticals Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pharmaceuticals's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Pharmaceuticals (BOM:500660) Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400 030
GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.

GlaxoSmithKline Pharmaceuticals (BOM:500660) Headlines

No Headlines